Ebola virus disease: roles and considerations for pharmacists.
Identifieur interne : 000531 ( Main/Exploration ); précédent : 000530; suivant : 000532Ebola virus disease: roles and considerations for pharmacists.
Auteurs : Anthony J. Guarascio [États-Unis] ; Andrew C. Faust [États-Unis] ; Lyndsay Sheperd [États-Unis] ; Lauren A. O'Donnell [États-Unis]Source :
- The Annals of pharmacotherapy [ 1542-6270 ] ; 2015.
Descripteurs français
- KwdFr :
- MESH :
- organisation et administration : Pharmacie d'hôpital.
- Fièvre hémorragique à virus Ebola, Humains, Lutte contre l'infection, Maladie grave, Pharmaciens.
English descriptors
- KwdEn :
- MESH :
- organization & administration : Pharmacy Service, Hospital.
- therapy : Hemorrhagic Fever, Ebola.
- Critical Illness, Humans, Infection Control, Pharmacists.
Abstract
Ebola virus disease (EVD) poses significant clinical care implications for pharmacists. Emergency preparedness efforts should be undertaken to ensure vital response to EVD. Pharmacists should consider factors such as enhanced use of resources for front-line EVD patient care along with procurement of investigational medications. Appropriate and timely preparation, distribution, and administration of treatment for patients with EVD in the setting of substantial critical illness as well as infection control measures are essential. Aggressive supportive care and early, goal-directed therapy are cornerstones of therapy, whereas investigational treatments for EVD will likely play a larger, more well-defined role as future clinical trials are conducted.
DOI: 10.1177/1060028014561782
PubMed: 25429092
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000736
- to stream PubMed, to step Curation: 000736
- to stream PubMed, to step Checkpoint: 000736
- to stream Ncbi, to step Merge: 003F82
- to stream Ncbi, to step Curation: 003F82
- to stream Ncbi, to step Checkpoint: 003F82
- to stream Main, to step Merge: 000531
- to stream Main, to step Curation: 000531
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ebola virus disease: roles and considerations for pharmacists.</title><author><name sortKey="Guarascio, Anthony J" sort="Guarascio, Anthony J" uniqKey="Guarascio A" first="Anthony J" last="Guarascio">Anthony J. Guarascio</name><affiliation wicri:level="2"><nlm:affiliation>Mylan School of Pharmacy at Duquesne University, Pittsburgh, PA, USA guarascioa@duq.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Mylan School of Pharmacy at Duquesne University, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Faust, Andrew C" sort="Faust, Andrew C" uniqKey="Faust A" first="Andrew C" last="Faust">Andrew C. Faust</name><affiliation wicri:level="2"><nlm:affiliation>Texas Health Presbyterian Hospital, Dallas, TX, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Texas Health Presbyterian Hospital, Dallas, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Sheperd, Lyndsay" sort="Sheperd, Lyndsay" uniqKey="Sheperd L" first="Lyndsay" last="Sheperd">Lyndsay Sheperd</name><affiliation wicri:level="2"><nlm:affiliation>Texas Health Presbyterian Hospital, Dallas, TX, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Texas Health Presbyterian Hospital, Dallas, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="O Donnell, Lauren A" sort="O Donnell, Lauren A" uniqKey="O Donnell L" first="Lauren A" last="O'Donnell">Lauren A. O'Donnell</name><affiliation wicri:level="2"><nlm:affiliation>Mylan School of Pharmacy at Duquesne University, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Mylan School of Pharmacy at Duquesne University, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25429092</idno><idno type="pmid">25429092</idno><idno type="doi">10.1177/1060028014561782</idno><idno type="wicri:Area/PubMed/Corpus">000736</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000736</idno><idno type="wicri:Area/PubMed/Curation">000736</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000736</idno><idno type="wicri:Area/PubMed/Checkpoint">000736</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000736</idno><idno type="wicri:Area/Ncbi/Merge">003F82</idno><idno type="wicri:Area/Ncbi/Curation">003F82</idno><idno type="wicri:Area/Ncbi/Checkpoint">003F82</idno><idno type="wicri:Area/Main/Merge">000531</idno><idno type="wicri:Area/Main/Curation">000531</idno><idno type="wicri:Area/Main/Exploration">000531</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Ebola virus disease: roles and considerations for pharmacists.</title><author><name sortKey="Guarascio, Anthony J" sort="Guarascio, Anthony J" uniqKey="Guarascio A" first="Anthony J" last="Guarascio">Anthony J. Guarascio</name><affiliation wicri:level="2"><nlm:affiliation>Mylan School of Pharmacy at Duquesne University, Pittsburgh, PA, USA guarascioa@duq.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Mylan School of Pharmacy at Duquesne University, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Faust, Andrew C" sort="Faust, Andrew C" uniqKey="Faust A" first="Andrew C" last="Faust">Andrew C. Faust</name><affiliation wicri:level="2"><nlm:affiliation>Texas Health Presbyterian Hospital, Dallas, TX, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Texas Health Presbyterian Hospital, Dallas, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Sheperd, Lyndsay" sort="Sheperd, Lyndsay" uniqKey="Sheperd L" first="Lyndsay" last="Sheperd">Lyndsay Sheperd</name><affiliation wicri:level="2"><nlm:affiliation>Texas Health Presbyterian Hospital, Dallas, TX, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Texas Health Presbyterian Hospital, Dallas, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="O Donnell, Lauren A" sort="O Donnell, Lauren A" uniqKey="O Donnell L" first="Lauren A" last="O'Donnell">Lauren A. O'Donnell</name><affiliation wicri:level="2"><nlm:affiliation>Mylan School of Pharmacy at Duquesne University, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Mylan School of Pharmacy at Duquesne University, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author></analytic><series><title level="j">The Annals of pharmacotherapy</title><idno type="eISSN">1542-6270</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Critical Illness</term><term>Hemorrhagic Fever, Ebola (therapy)</term><term>Humans</term><term>Infection Control</term><term>Pharmacists</term><term>Pharmacy Service, Hospital (organization & administration)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Fièvre hémorragique à virus Ebola ()</term><term>Humains</term><term>Lutte contre l'infection</term><term>Maladie grave</term><term>Pharmacie d'hôpital (organisation et administration)</term><term>Pharmaciens</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Pharmacie d'hôpital</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Pharmacy Service, Hospital</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Hemorrhagic Fever, Ebola</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Critical Illness</term><term>Humans</term><term>Infection Control</term><term>Pharmacists</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Fièvre hémorragique à virus Ebola</term><term>Humains</term><term>Lutte contre l'infection</term><term>Maladie grave</term><term>Pharmaciens</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Ebola virus disease (EVD) poses significant clinical care implications for pharmacists. Emergency preparedness efforts should be undertaken to ensure vital response to EVD. Pharmacists should consider factors such as enhanced use of resources for front-line EVD patient care along with procurement of investigational medications. Appropriate and timely preparation, distribution, and administration of treatment for patients with EVD in the setting of substantial critical illness as well as infection control measures are essential. Aggressive supportive care and early, goal-directed therapy are cornerstones of therapy, whereas investigational treatments for EVD will likely play a larger, more well-defined role as future clinical trials are conducted.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li><li>Texas</li></region></list><tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Guarascio, Anthony J" sort="Guarascio, Anthony J" uniqKey="Guarascio A" first="Anthony J" last="Guarascio">Anthony J. Guarascio</name></region><name sortKey="Faust, Andrew C" sort="Faust, Andrew C" uniqKey="Faust A" first="Andrew C" last="Faust">Andrew C. Faust</name><name sortKey="O Donnell, Lauren A" sort="O Donnell, Lauren A" uniqKey="O Donnell L" first="Lauren A" last="O'Donnell">Lauren A. O'Donnell</name><name sortKey="Sheperd, Lyndsay" sort="Sheperd, Lyndsay" uniqKey="Sheperd L" first="Lyndsay" last="Sheperd">Lyndsay Sheperd</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000531 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000531 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25429092
|texte= Ebola virus disease: roles and considerations for pharmacists.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25429092" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |